Hi,
I see our new Chinese holder is developing their own checkpoint blocker drug.
Obviously they want Cavatak to improve response rates and lessen adverse effects in combination with their candidate .
Now its game on with BMS and Merck.
IMO they are now under pressure to make a solid offer or miss the boat.
Aloha.